Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
The addition of GIP helps tirzepatide enhance fat metabolism and insulin sensitivity, leading to greater weight loss in some cases
(Tirzepatide is the active ingredient in Eli Lilly's obesity drug Zepbound.) She'd been taking the drugs already, from a local provider, and called them "life-changing," but made the switch to Zappy hoping to save money
Published literature: Documented effects on sleep architecture and cortisol modulation in published studies Therapeutic Peptides Comparison Table Peptide Category FDA Status Primary Research Application BPC-157 Tissue Repair Category 1 (2026) Tendon, ligament, GI repair TB-500 Tissue Repair Category 1 (2026) Soft tissue, cell migration Retatrutide Metabolic Phase 3 trials Obesity, metabolic syndrome Tirzepatide Metabolic FDA-approved Type 2 diabetes, obesity Tesamorelin Metabolic / GH FDA-approved Lipodystrophy, visceral fat GHK-Cu Skin / Repair Not approved Wound healing, collagen CJC-1295 GH Secretagogue Category 1 (2026) Growth hormone release Ipamorelin GH Secretagogue Category 1 (2026) Selective GH release Selank Cognitive Category 1 (2026) Anxiety, GABA modulation Semax Cognitive Category 1 (2026) Memory, BDNF pathways KPV Anti-inflammatory Not approved Gut inflammation, skin PT-141 Neurological FDA-approved Sexual health (HSDD) SS-31 Mitochondrial FDA-approved Barth syndrome, mito dysfunction MOTS-c Mitochondrial Not approved Insulin sensitivity, exercise Humanin Cytoprotective Not approved Neuroprotection, aging DSIP Neurological Not approved Sleep regulation 2026 FDA Peptide Reclassification On February 27, 2026, HHS Secretary Robert F
The real question is no longer Can LDL-C be too low? It is: Why are so many high-risk patients still above target? The greatest danger is not an LDL-C of 20 mg/dL
US$ 24.15
US$ 23.85
US$ 21.70
US$ 29.14
